PERSON DIRECTORY
Abe Ceesay
Abe Ceesay appears in 1 indexed conversation across Biotech Hangout. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
1 EPISODE1 SHOW
Language
Episode 130 - Feburary 7, 2025
Daphne ZoharPaul MatteisBrian SkorneyTim OplerAbe Ceesay
Biotech sentiment improved after JPM, but the XBI’s 12% lag versus the S&P kept the shift “less negative,” not risk-on.Stronger 2025 pharma M&A capacity, wall-crossed PIPEs, and GH Research’s 15-to-16-point MADRS difference offered catalysts while exposing access and disclosure tensions.Symbravo’s launch, Ingrezza’s Part D pressure, and Eylea biosimilar erosion leave reimbursement, competition, and execution as key variables.